FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2982944912> ?p ?o ?g. }

• W2982944912 endingPage "62" @default.
• W2982944912 startingPage "57" @default.
• W2982944912 abstract "Gallbladder cancer (GBC) is a rare and fatal biliary tract malignancy. Genetic derangements are one of many factors that determine the prognosis of GBC. In this study, the expression of the stratifin (SFN) gene encoding 14-3-3 sigma protein, which is reported to be associated with the metastatic property of cholangiocarcinoma cells, was investigated in GBC. Formalin-fixed paraffin-embedded cancer (n = 37) and non-cancer control tissues (n = 14) of gallbladders from patients who underwent surgical resection from January 2006 to May 2015 were retrieved. The expression of SFN normalized with that of ACTB was determined using RT-qPCR. Multivariate analysis of factors affecting disease-free survival (DFS) and overall survival (OS) including the type of SFN expression was performed. The average expression level of SFN in cancer was higher than that in control tissues (p = 0.002). The relative SFN expression in cancer tissue was classified as overexpression (n = 14) and control level expression (n = 23) according to the receiver operating characteristic (ROC) curves for discriminating early GBC recurrence or metastasis after surgery. The SFN overexpression group was associated with lower rates of distant metastasis and early tumor recurrence following resection. The univariate analysis demonstrated factors affecting DFS, including resection margin (p < 0.001), lymphovascular invasion (p = 0.040), perineural invasion (p = 0.046), and SFN expression (p < 0.001). The multivariate analysis revealed that the resection margin (p = 0.019) and SFN expression (P = 0.040) were independent prognostic factors of DFS. To achieve the longest survival, margin-free resection is recommended. The overexpression of SFN in GBC is associated with better prognosis, lower rates of early cancer recurrence, and distant metastasis following resection. SFN expression might be a novel prognostic biomarker in GBC treatment. Further studies to elucidate the role of SFN might unveil its clinical benefit in cancer treatment regimens." @default.
• W2982944912 created "2019-11-22" @default.
• W2982944912 creator A5006351517 @default.
• W2982944912 creator A5009829554 @default.
• W2982944912 creator A5014440306 @default.
• W2982944912 creator A5014552314 @default.
• W2982944912 creator A5018527571 @default.
• W2982944912 creator A5022427300 @default.
• W2982944912 creator A5023729454 @default.
• W2982944912 creator A5036994983 @default.
• W2982944912 creator A5059282181 @default.
• W2982944912 creator A5062862531 @default.
• W2982944912 creator A5063296842 @default.
• W2982944912 creator A5072519658 @default.
• W2982944912 creator A5080830400 @default.
• W2982944912 creator A5088109789 @default.
• W2982944912 date "2020-03-01" @default.
• W2982944912 modified "2023-10-01" @default.
• W2982944912 title "Role of stratifin (14-3-3 sigma) in adenocarcinoma of gallbladder: A novel prognostic biomarker" @default.
• W2982944912 cites W1480537273 @default.
• W2982944912 cites W1925416510 @default.
• W2982944912 cites W1963593662 @default.
• W2982944912 cites W1969909442 @default.
• W2982944912 cites W1999480597 @default.
• W2982944912 cites W2006217954 @default.
• W2982944912 cites W2007755580 @default.
• W2982944912 cites W2034382247 @default.
• W2982944912 cites W2061202383 @default.
• W2982944912 cites W2085113277 @default.
• W2982944912 cites W2091823826 @default.
• W2982944912 cites W2109839635 @default.
• W2982944912 cites W2114139737 @default.
• W2982944912 cites W2119993129 @default.
• W2982944912 cites W2121589581 @default.
• W2982944912 cites W2132227626 @default.
• W2982944912 cites W2132577566 @default.
• W2982944912 cites W2140009101 @default.
• W2982944912 cites W2363042890 @default.
• W2982944912 cites W2788915030 @default.
• W2982944912 doi "https://doi.org/10.1016/j.suronc.2019.10.022" @default.
• W2982944912 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31751820" @default.
• W2982944912 hasPublicationYear "2020" @default.
• W2982944912 type Work @default.
• W2982944912 sameAs 2982944912 @default.
• W2982944912 citedByCount "11" @default.
• W2982944912 countsByYear W29829449122020 @default.
• W2982944912 countsByYear W29829449122021 @default.
• W2982944912 countsByYear W29829449122022 @default.
• W2982944912 countsByYear W29829449122023 @default.
• W2982944912 crossrefType "journal-article" @default.
• W2982944912 hasAuthorship W2982944912A5006351517 @default.
• W2982944912 hasAuthorship W2982944912A5009829554 @default.
• W2982944912 hasAuthorship W2982944912A5014440306 @default.
• W2982944912 hasAuthorship W2982944912A5014552314 @default.
• W2982944912 hasAuthorship W2982944912A5018527571 @default.
• W2982944912 hasAuthorship W2982944912A5022427300 @default.
• W2982944912 hasAuthorship W2982944912A5023729454 @default.
• W2982944912 hasAuthorship W2982944912A5036994983 @default.
• W2982944912 hasAuthorship W2982944912A5059282181 @default.
• W2982944912 hasAuthorship W2982944912A5062862531 @default.
• W2982944912 hasAuthorship W2982944912A5063296842 @default.
• W2982944912 hasAuthorship W2982944912A5072519658 @default.
• W2982944912 hasAuthorship W2982944912A5080830400 @default.
• W2982944912 hasAuthorship W2982944912A5088109789 @default.
• W2982944912 hasConcept C10515644 @default.
• W2982944912 hasConcept C121608353 @default.
• W2982944912 hasConcept C126322002 @default.
• W2982944912 hasConcept C141071460 @default.
• W2982944912 hasConcept C142724271 @default.
• W2982944912 hasConcept C143998085 @default.
• W2982944912 hasConcept C159110652 @default.
• W2982944912 hasConcept C2776534502 @default.
• W2982944912 hasConcept C2777154038 @default.
• W2982944912 hasConcept C2778132481 @default.
• W2982944912 hasConcept C2778740770 @default.
• W2982944912 hasConcept C2779013556 @default.
• W2982944912 hasConcept C2779399171 @default.
• W2982944912 hasConcept C38180746 @default.
• W2982944912 hasConcept C58471807 @default.
• W2982944912 hasConcept C71924100 @default.
• W2982944912 hasConceptScore W2982944912C10515644 @default.
• W2982944912 hasConceptScore W2982944912C121608353 @default.
• W2982944912 hasConceptScore W2982944912C126322002 @default.
• W2982944912 hasConceptScore W2982944912C141071460 @default.
• W2982944912 hasConceptScore W2982944912C142724271 @default.
• W2982944912 hasConceptScore W2982944912C143998085 @default.
• W2982944912 hasConceptScore W2982944912C159110652 @default.
• W2982944912 hasConceptScore W2982944912C2776534502 @default.
• W2982944912 hasConceptScore W2982944912C2777154038 @default.
• W2982944912 hasConceptScore W2982944912C2778132481 @default.
• W2982944912 hasConceptScore W2982944912C2778740770 @default.
• W2982944912 hasConceptScore W2982944912C2779013556 @default.
• W2982944912 hasConceptScore W2982944912C2779399171 @default.
• W2982944912 hasConceptScore W2982944912C38180746 @default.
• W2982944912 hasConceptScore W2982944912C58471807 @default.
• W2982944912 hasConceptScore W2982944912C71924100 @default.
• W2982944912 hasFunder F4320322401 @default.
• W2982944912 hasFunder F4320322437 @default.

• next